Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Kymera Therapeutics Announces Proposed Public Offering
-
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
-
Kymera Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Kymera Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Kymera Therapeutics (KYMR) Prices Upzised 4.755M Share Offering at $47/sh
-
Kymera Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Kymera Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Kymera Therapeutics (KYMR) Announces 4M Share Proposed Public Offering of Common Stock
-
Kymera Therapeutics Announces Proposed Public Offering of Common Stock
-
Kymera Therapeutics Announces Proposed Public Offering of Common Stock
-
Kymera Therapeutics to Present at Upcoming March Investor Conferences
-
Kymera Therapeutics to Present at Upcoming March Investor Conferences
-
UPDATE: Cowen Starts Kymera Therapeutics (KYMR) at Outperform
-
Kymera Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
-
Kymera Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
-
UPDATE: Kymera Therapeutics Inc. (KYMR) Prices 8.68M Share Upsized IPO at $20/Sh
-
Kymera Therapeutics Announces Pricing of Upsized Initial Public Offering
-
Kymera Therapeutics Announces Pricing of Upsized Initial Public Offering